Vitamin C and MEK Inhibitor PD0325901 Synergistically Promote Oligodendrocytes Generation by Promoting DNA

Xinyue Ren1,2, Ying Yang1,2,3, Min Wang1

  • 1State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

PubMed

Insights

Vitamin C and a MEK inhibitor promote oligodendrocyte differentiation by increasing 5-hydroxymethylcytosine (5hmC) DNA demethylation. This epigenetic modification is crucial for cell fate and holds potential for treating demyelination diseases.

Area of Science:

  • Epigenetics
  • Neuroscience
  • Cell Biology

Background:

  • DNA methylation and demethylation are critical epigenetic mechanisms governing gene expression and cell differentiation.
  • 5-hydroxymethylcytosine (5hmC) is a key intermediate in DNA demethylation, particularly important in brain development.
  • Oligodendrocyte progenitor cells (OPCs) differentiate into oligodendrocytes (OLs), essential for myelin sheath formation in the central nervous system.

Purpose of the Study:

  • To investigate the role of DNA demethylation via hydroxymethylation in Vitamin C (Vc) and MEK inhibitor PD0325901-induced OPC-to-OL differentiation.
  • To determine if TET1 is involved in the differentiation process promoted by Vc and PD0325901.
  • To explore the potential of Vc and PD0325901 as a combination therapy for demyelination diseases.

Main Methods:

  • Treatment of OPCs with Vitamin C (Vc) and MEK inhibitor PD0325901.
  • Assessment of OPC-to-OL differentiation.
  • Inhibition of 5hmC formation to evaluate its role in Vc- and PD0325901-stimulated differentiation.
  • Analysis of TET1 involvement in the differentiation process.

Main Results:

  • Vc and PD0325901 significantly promote OPC-to-OL differentiation.
  • This promotion is mediated by inducing DNA demethylation through hydroxymethylation (5hmC).
  • Blocking 5hmC formation abrogated the differentiation-promoting effects of Vc and PD0325901.
  • TET1 was found not to be involved in the Vc- and PD0325901-promoted OL generation.
  • A synergistic effect was observed between Vc and PD0325901 in inducing OL generation.

Conclusions:

  • Vitamin C and PD0325901 enhance OPC-to-OL differentiation by increasing 5hmC levels, indicating a role for DNA hydroxymethylation in this process.
  • The findings suggest that TET1 is not the primary mediator of this effect.
  • The synergistic action of Vc and PD0325901 presents a promising therapeutic strategy for demyelination disorders.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...